RP
Robin Praeger
OtherActiveManaging Director/CFO at Versant Ventures
62
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Robin Praeger.
Investment Thesis & Strategy
Robin Praeger, as Managing Director/CFO at Versant Ventures, invests in various stages of fintech, human capital/HR tech, and legal tech companies, likely seeking innovative solutions with strong financial models.
Portfolio Companies
Selected investments from their portfolio of 62 companies
I
Ivantis
Other · , 0
B
BlueRock Therapeutics
Biotech · Series C+, 0
S
Sebacia
Healthcare · Series B, 0
R
Repare Therapeutics
Biotech · Series A, 0
E
Enterprise Therapeutics
Biotech · Series A, 0
K
Kinestral Technologies
Cleantech · Series B, 0
I
Intuity Medical
Healthcare · Series B, 0
M
Metavention
Healthcare · Series A, 0
T
Tempest Therapeutics
Biotech · Series B, 0
B
Bright Peak Therapeutics
Biotech · Series A, 0
V
Veran Medical Technologies
Healthcare · Series A, 0
R
Respicardia
Healthcare · Series B, 0
Frequently Asked Questions
Robin Praeger focuses on Seed stage investments.
Related Investors
Bill Coughran
San Francisco, United States · 104 deals
Dave Lambert
San Francisco, United States · 101 deals
Arun Mathew
San Francisco, United States · 99 deals
Ash Rust
San Francisco, United States · 96 deals
Alex Tran
San Francisco, United States · 95 deals
Randy Williams
San Francisco, United States · 95 deals